Prognose des Bioproduktionsmarkts im asiatisch-pazifischen Raum bis 2030 – Regionale Analyse – nach Produkt (Biologika und Biosimilars, Impfstoffe, Zell- und Gentherapien, Nukleinsäuretherapeutika und andere), Anwendung (rheumatoide Arthritis, hämatologische Erkrankungen, Krebs, Diabetes, Herz-Kreislauf-Erkrankungen und andere), Ausrüstung (Upstream-Ausrüstung, Downstream-Ausrüstung, Bioreaktoren sowie Verbrauchsmaterialien und Zubehör) und Endverbraucher (Biopharmazeutische Unternehmen, Auftragshersteller und andere)
Patentablauf bei Blockbuster-Biologika beflügelt den Markt für Bioproduktion im asiatisch-pazifischen Raum
Biologika stellen vielversprechende neue Therapien für bislang unheilbare Krankheiten dar und gewinnen auf dem Pharmamarkt zunehmend an Bedeutung. Patente auf Original-Biologika laufen voraussichtlich in den kommenden Jahren aus.
Die voraussichtlichen Patent- und Exklusivitätsablaufdaten für die meistverkauften Biologika sind in der folgenden Tabelle aufgeführt.
Verfallsdaten für Biologika
Biologika
Verfallsdaten
Avastin
Januar 2022
Cyramza
Mai 2023
Adcetris
August 2023
Abthrax
Oktober 2024
Gazyva/Gazyvaro
November 2024
Darzalex
Mai 2026
Ocrevus
April 2027
Emgality
September 2028
Hemlibra
Februar 2028
Llumetri
März 2028
Imfinzi
September 2028
Mylotarg
April 2028
Imfinzi
September 2028
Mylotarg
April 2028
Sylvant
Juli 2034
Der Ablauf des Patents und anderer Rechte an geistigem Eigentum für Original-Biologika wird in Zukunft die Einführung neuer Biosimilars erforderlich machen. Infolgedessen wird der Wettbewerb zwischen den Marktteilnehmern in der Branche in den kommenden Jahren zunehmen. Daher wird erwartet, dass der Ablauf des Patents für Blockbuster-Biologika im Prognosezeitraum lukrative Möglichkeiten für den Bioproduktionsmarkt schafft.
Überblick über den Bioproduktionsmarkt im asiatisch-pazifischen Raum
Der Bioproduktionsmarkt im asiatisch-pazifischen Raum ist in China, Japan, Indien, Südkorea, Australien, Südkorea und den Rest des asiatisch-pazifischen Raums unterteilt. Das Wachstum des Marktes im asiatisch-pazifischen Raum wird aufgrund von Faktoren wie dem wachsenden Bedarf an überlegenen Behandlungslösungen, der zunehmenden Konzentration auf Forschungs- und Entwicklungsaktivitäten und günstigen regulatorischen Szenarien voraussichtlich schneller voranschreiten. Darüber hinaus werden voraussichtlich steigende Investitionen und die Entwicklung der Gesundheitsinfrastruktur zur Förderung der Forschungsaktivitäten den Bioproduktionsmarkt im asiatisch-pazifischen Raum zwischen 2022 und 2030 antreiben.
In China steigt die Nachfrage nach Gesundheitsversorgung rasant an. Faktoren wie die wachsende geriatrische Bevölkerung, die steigende Zahl chronischer Krankheiten und zunehmende staatliche Initiativen im Gesundheitssektor treiben den Zelltherapiemarkt in China an. Verbesserungen bei der Grund- und privaten Krankenversicherung haben das Wachstum des medizinischen Sektors im Land ebenfalls beschleunigt. Die steigenden Einkommen haben zu einer Nachfrage nach anspruchsvolleren Gesundheitsdienstleistungen geführt. Der Anstieg der geriatrischen Bevölkerung hat zu einer Zunahme der Fachärzteschaft im Land geführt. In China wird die zunehmende Verbreitung von Krebs wahrscheinlich die Einführung der Zelltherapie fördern. Laut dem Nationalen Zentralen Krebsregister Chinas wurden in China 4,3 Millionen neue Krebsfälle registriert.
Umsatz und Prognose des Bioproduktionsmarkts im asiatisch-pazifischen Raum bis 2030 (in Mio. USD)
Segmentierung des Bioproduktionsmarkts im asiatisch-pazifischen Raum
Der Bioproduktionsmarkt im asiatisch-pazifischen Raum ist in Produkt, Anwendung, Ausrüstung, Endbenutzer und Land unterteilt.
Basierend auf dem Produkt ist der Bioproduktionsmarkt im asiatisch-pazifischen Raum in Biologika und Biosimilars, Impfstoffe, Zell- und Gentherapien, Nukleinsäuretherapeutika und andere segmentiert. Das Segment Biologika und Biosimilars hatte 2022 den größten Marktanteil an der Bioproduktion im asiatisch-pazifischen Raum.
In Bezug auf die Anwendung ist der Markt für Bioproduktion im asiatisch-pazifischen Raum in rheumatoide Arthritis, hämatologische Erkrankungen, Krebs, Diabetes, Herz-Kreislauf-Erkrankungen und andere unterteilt. Das Segment Krebs hatte 2022 den größten Marktanteil an der Bioproduktion im asiatisch-pazifischen Raum.
Nach Ausrüstung ist der Markt für Bioproduktion im asiatisch-pazifischen Raum in vorgelagerte Ausrüstung, nachgelagerte Ausrüstung, Bioreaktoren sowie Verbrauchsmaterialien und Zubehör unterteilt. Das Segment Verbrauchsmaterialien und Zubehör hatte 2022 den größten Marktanteil an der Bioproduktion im asiatisch-pazifischen Raum.
In Bezug auf den Endverbraucher ist der Markt für Bioproduktion im asiatisch-pazifischen Raum in biopharmazeutische Unternehmen, Auftragsfertigungsunternehmen und andere unterteilt. Das Segment biopharmazeutische Unternehmen hatte 2022 den größten Marktanteil an der Bioproduktion im asiatisch-pazifischen Raum.
Nach Ländern ist der Markt für Bioproduktion im asiatisch-pazifischen Raum in Australien, China, Indien, Japan, Südkorea und den Rest des asiatisch-pazifischen Raums unterteilt. China dominierte 2022 den Marktanteil der Bioproduktion im asiatisch-pazifischen Raum.
Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd und Bio-Rad Laboratories Inc. sind einige der führenden Unternehmen auf dem Bioproduktionsmarkt im asiatisch-pazifischen Raum.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Asia Pacific Market Analysis
5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Asia Pacific: Bioproduction Market
10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. bbi-biotech GmbH
3. Danaher Corp
4. Sartorius AG
5. FUJIFILM Irvine Scientific Inc
6. Thermo Fisher Scientific Inc
7. Merck KGaA
8. F. Hoffmann-La Roche Ltd
9. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.